Recurrent Rectal Cancer Completed Phase 1 Trials for Vorinostat (DB02546)

Also known as: Rectal cancer recurrent / Carcinoma rectum recurrent / Rectal carcinoma recurrent / Carcinoma of rectum recurrent

IndicationStatusPhase
DBCOND0028583 (Recurrent Rectal Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00138177Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsTreatment